HYPERTENSIVE CRISIS: TOWARDS OPTIMIZATION OF TREATMENT


如何引用文章

全文:

详细

The article discusses modern approaches to the diagnosis and treatment of hypertensive crisis (HC). It is emphasized that the significant prevalence of HC is one of the most prominent indicators of the low quality of management of hypertensive patients, and it at least partially explains the high incidence of fatal and disabling cardiovascular complications, including stroke. Among the modern drugs used for treatment HC, Urapidil (Ebrantil) claim attention; its antihypertensive action is determined by the blockade of postsynaptic α1-adrenergic receptors, as well as affinity (agonism) to the central serotonin 5NT1A receptors.

作者简介

V Fomin

Viktor Fomin

参考

  1. McRae RPJ, Liebson PR. Hypertensive crisis. Med Clin North Am 1986;70:749-67.
  2. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-17.
  3. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 2007;131:1949-62.
  4. Комитет экспертов РМОАГ/ВНОК. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр). М., 2008.
  5. Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile, and previous care of 100 cases. Am J Public Health 1988;78:636-40.
  6. Шальнова С.А. Проблемы лечения артериальной гипертонии // Кардиоваскулярная терапия и профилактика. 2003. № 3. С. 17-21.
  7. Кобалава Ж.Д., Гудков К.М. Гипертонические кризы: существуют ли реальные противоречия в классификации и лечении? // Сердце. 2003. Т. 2. № 3. С. 116-27.
  8. Колос И.П., Чазова И.Е., Терещенко С.Н. и др. Риск сердечно-сосудистых осложнений у больных частыми гипертоническими кризами // Терапевтический архив. 2009. Т. 81(9). С. 9-12.
  9. Reisch N, Peczkowska M, Januszewicz A, et al. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 2006;24(12):2331-39.
  10. Cryer PE. Phaeochromocytoma. Clin Endocrinol Metab 1985;14(1):203-20.
  11. Mannelli M, Ianni L, Cilotti A, et al. Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 1999;141(6):619-24.
  12. Mosso L, Carvajal C, Gonzales A, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003;42:161-65.
  13. Чазова И.Е., Фомин В.В. Резистентная артериальная гипертензия // Терапевтический архив. 2008. № 6. С. 80-85.
  14. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001;14(12):1263-69.
  15. Tisdale JE, Huang MB, Borzak S, et al. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 2004;21:420-24.
  16. Shea S, Misra D, Ehrlich MH, et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority populaton. N Engl J Med 1992;327:776-81.
  17. Tumlin JA, Dunbar LM, Oparil S, et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial: Fenoldopam Study Group. Acad Emerg Med 2000;7:653-62.
  18. Терещенко С.Н. Гипертонические кризы: диагностика и лечение. В кн.: Чазов Е.И., Чазова И.Е. (ред.) Руководство по артериальной гипертонии. М., 2005. С. 676-689.
  19. Grossman E, Messerli FH, Grodzicki T, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-31.
  20. Dooley M, Goa KL. Urapidil. A reappraisal of its use in the management of hypertension. Drugs 1998;56(5):929-55.
  21. Buch J. Urapidil, a dual-acting antihypertensive agent: Current usage considerations. Adv Ther 2010;27(7):426-43.
  22. Hess W, Schulte-Sasse U, Tarnow J, et al. Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery. Eur J Anaesthesiol 1985;2(1):21-27.
  23. Stoschitzky K, Stoschitzky G, Wonisch M, et al. Differential effects of urapidil and doxazosin on heart rate. Eur J Clin Pharmacol 2007;63(3):259-62.
  24. Wacker JR, Wagner BK, Briese V, et al. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 2006;127(2):160-65.
  25. Wacker J, Werner P, Walter-Sack I, et al. Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. Nephrol Dial Transplant 1998;13(2):318-25.
  26. Arosio E, Pancera P, Sheiban I, et al. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil. J Hum Hypertens 1996;10(3):171-76.
  27. Alijotas-Reig J, Bove-Farre I, de Cabo-Frances F, et al. Effectiveness and safety of prehospital urapidil for hypertensive emergencies. Am J Emerg Med 2001;19(2):130-33.
  28. Woisetschlager C, Bur A, Vlcek M, et al. Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies. J Hum Hypertens 2006;20(9):707-09.
  29. Adnot S, Andrivet P, Piquet J, et al. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 1988;137(5):1068-74.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##